# Cost-effectiveness of PCSK9 Inhibitor Therapy in Patients With Heterozygous Familial Hypercholesterolemia or Atherosclerotic Cardiovascular Disease

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/cost-effectiveness-of-pcsk9-inhibitor-therapy-in-patients-with-heterozygous/

## Facts

| Field | Value |
| --- | --- |
| Author Names | Dhruv S. Kazi,Andrew E. Moran,Pamela G. Coxson,Joanne Penko,Daniel A. Ollendorf,Steven D. Pearson,Jeffrey A. Tice,David Guzman,Kirsten Bibbins‐Domingo |
| Citations | 384 |
| DOI | 10.1001/jama.2016.11004 |
| Fields | Medicine |
| Open Access | true |
| OA Status | bronze |
| OA URL | https://jamanetwork.com/journals/jama/articlepdf/2544639/joi160091.pdf |
| OpenAlex ID | https://openalex.org/W2511907480 |
| PMID | 27533159 |
| Type | article |
| Year | 2016 |

## Paper authors

- [Steven D. Pearson](https://scholariq.org/researchers/steven-d-pearson/)

## Paper journal

- [JAMA](https://scholariq.org/journals/jama/)

## Paper primary topic

- [Lipoproteins and Cardiovascular Health](https://scholariq.org/topics/lipoproteins-and-cardiovascular-health/)

## Paper topics

- [Lipoproteins and Cardiovascular Health](https://scholariq.org/topics/lipoproteins-and-cardiovascular-health/)
- [Medication Adherence and Compliance](https://scholariq.org/topics/medication-adherence-and-compliance/)
- [Peripheral Artery Disease Management](https://scholariq.org/topics/peripheral-artery-disease-management/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.